Xiu-Yu Shi
Overview
Explore the profile of Xiu-Yu Shi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meng Y, Wan L, Yang X, Han F, Zhang M, He W, et al.
J Assist Reprod Genet
. 2025 Feb;
PMID: 39937390
Aim: Assisted reproductive technology (ART) is an invaluable strategy for preventing the inheritance of genetic disorders and promoting the birth of healthy children. Nevertheless, the general public's limited understanding of...
2.
Zhang M, Wu D, Yu L, Li H, Sun D, Liang J, et al.
World J Pediatr
. 2025 Jan;
21(2):149-158.
PMID: 39745620
Background: Glucose transporter 1 deficiency syndrome (Glut1DS) was initially reported by De Vivo and colleagues in 1991. This disease arises from mutations in the SLC2A1 and presents with a broad...
3.
Hu L, Wan L, Wang Q, Shi X, Meng Y, Yang X, et al.
Front Immunol
. 2023 Dec;
14:1306338.
PMID: 38149249
Perforin is essentially involved in the granule-dependent killing activities of cytotoxic T lymphocytes and NK cells. Monoallelic PRF1 mutation increases the risk of autoimmune diseases, and biallelic PRF1 mutation causes...
4.
He W, Wang Q, Li J, Wang Y, Luo X, Wan L, et al.
World J Pediatr
. 2023 Dec;
20(8):834-847.
PMID: 38070098
Background: Infantile epileptic spasms syndrome (IESS) is a serious disease in infants, and it usually evolves to other epilepsy types or syndromes, especially refractory or super-refractory focal epilepsies. Although adrenocorticotropic...
5.
Zou L, Shi X, Lu Q, Ju J
Epilepsia
. 2023 Oct;
64(12):3406-3407.
PMID: 37846512
No abstract available.
6.
Shi X, Ju J, Lu Q, Hu L, Tian Y, Guo G, et al.
Epilepsia
. 2023 Jul;
64(10):2667-2678.
PMID: 37522416
Objective: Bone metabolism can be influenced by a range of factors. We selected children with self-limited epilepsy with centrotemporal spikes (SeLECTS) and lifestyles similar to those of healthy children to...
7.
Wan L, He W, Wang Y, Xu Y, Lu Q, Zhang M, et al.
Ther Adv Neurol Disord
. 2023 Jan;
15:17562864221138148.
PMID: 36601084
Background: Vigabatrin (VGB) is currently the most widely prescribed first-line medication for individuals with infantile spasms (IS) and especially for those with tuberous sclerosis complex (TSC), with demonstrated efficacy. Meanwhile,...
8.
Wan L, Zhang C, Zhu G, Chen J, Shi X, Wang J, et al.
World J Pediatr
. 2022 Jul;
18(11):761-770.
PMID: 35906344
Background: Even though adrenocorticotropic hormone (ACTH) demonstrated powerful efficacy in the initially successful treatment of infantile spasms (IS), nearly half of patients have experienced a relapse. We sought to investigate...
9.
Wan L, Lei Y, Liu X, Chen J, Yeh C, Zhang C, et al.
Neurol Ther
. 2022 Apr;
11(2):835-849.
PMID: 35428921
Introduction: Even though adrenocorticotropic hormone (ACTH) demonstrated powerful efficacy in the initially successful treatment of infantile spasms (IS), nearly one-half of patients whose spasms were once suppressed experienced relapse. There...
10.
Xu Y, Wan L, He W, Wang Y, Wang Q, Luo X, et al.
Epilepsia
. 2021 Nov;
63(1):120-129.
PMID: 34786694
Objective: Vigabatrin (VGB) is the first-line treatment for infantile spasms (IS). Previous studies have shown that VGB exposure may cause vigabatrin-associated brain abnormalities on magnetic resonance imaging (MRI) (VABAM). Based...